Utility of Follow-up Coronavirus Disease 2019 (COVID-19) Antigen Tests After Acute Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Healthcare Personnel | Zendy

Aaron J. Tande | Zendy; Melanie D. Swift | Zendy; Douglas W. Challener | Zendy; Elie F. Berbari | Zendy; Christopher P. Tommaso | Zendy; Darrin R Christopherson | Zendy; Matthew J. Binnicker | Zendy; Laura E. Breeher | Zendy

Open Access

Utility of Follow-up Coronavirus Disease 2019 (COVID-19) Antigen Tests After Acute Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Healthcare Personnel

Author(s) -

Aaron J. Tande,

Melanie D. Swift,

Douglas W. Challener,

Elie F. Berbari,

Christopher P. Tommaso,

Darrin R Christopherson,

Matthew J. Binnicker,

Laura E. Breeher

Publication year - 2022

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciac235

Subject(s) - medicine , coronavirus , covid-19 , virology , isolation (microbiology) , pneumonia , disease , intensive care medicine , infectious disease (medical specialty) , outbreak , bioinformatics , biology

We report the utility of rapid antigen tests (RAgT) in a cohort of US healthcare personnel with COVID-19 infection who met symptom criteria to return to work at day 5 or later of isolation. 11.9% of initial RAgT were negative. RAgT can be helpful to guide return to work decisions.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research